1 Study Coverage 1.1 Tigecycline Product Introduction 1.2 Market by Type 1.2.1 Global Tigecycline Market Size Growth Rate by Type 1.4.2 Gram Positive Bacteria 1.4.3 Gram Negative Bacteria 1.3 Market by Application 1.3.1 Global Tigecycline Market Size Growth Rate by Application 1.3.2 Skin & Soft Tissue Infections 1.3.3 Complicated Intra-abdominal Infections 1.3.4 Community-acquired Bacterial Pneumonia 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Tigecycline Sales Estimates and Forecasts 2016-2027 2.2 Global Tigecycline Revenue Estimates and Forecasts 2016-2027 2.3 Global Tigecycline Revenue by Region: 2016 VS 2021 VS 2027 2.4 Global Top Tigecycline Regions by Sales 2.4.1 Global Top Tigecycline Regions by Sales (2016-2021) 2.4.2 Global Top Tigecycline Regions by Sales (2022-2027) 2.5 Global Top Tigecycline Regions by Revenue 2.5.1 Global Top Tigecycline Regions by Revenue (2016-2021) 2.5.2 Global Top Tigecycline Regions by Revenue (2022-2027) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Tigecycline Sales by Manufacturers 3.1.1 Global Top Tigecycline Manufacturers by Sales (2016-2021) 3.1.2 Global Top Tigecycline Manufacturers Market Share by Sales (2016-2021) 3.1.3 Global Top 10 and Top 5 Companies by Tigecycline Sales in 2020 3.2 Global Tigecycline Revenue by Manufacturers 3.2.1 Global Top Tigecycline Manufacturers by Revenue (2016-2021) 3.2.2 Global Top Tigecycline Manufacturers Market Share by Revenue (2016-2021) 3.2.3 Global Top 10 and Top 5 Companies by Tigecycline Revenue in 2020 3.3 Global Tigecycline Sales Price by Manufacturers 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Tigecycline Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Tigecycline Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Tigecycline Sales by Type 4.1.1 Global Tigecycline Historical Sales by Type (2016-2021) 4.1.2 Global Tigecycline Forecasted Sales by Type (2022-2027) 4.1.3 Global Tigecycline Sales Market Share by Type (2016-2027) 4.2 Global Tigecycline Revenue by Type 4.2.1 Global Tigecycline Historical Revenue by Type (2016-2021) 4.2.2 Global Tigecycline Forecasted Revenue by Type (2022-2027) 4.2.3 Global Tigecycline Revenue Market Share by Type (2016-2027) 4.3 Global Tigecycline Price by Type 4.3.1 Global Tigecycline Price by Type (2016-2021) 4.3.2 Global Tigecycline Price Forecast by Type (2022-2027) 5 Market Size by Application 5.1 Global Tigecycline Sales by Application 5.1.1 Global Tigecycline Historical Sales by Application (2016-2021) 5.1.2 Global Tigecycline Forecasted Sales by Application (2022-2027) 5.1.3 Global Tigecycline Sales Market Share by Application (2016-2027) 5.2 Global Tigecycline Revenue by Application 5.2.1 Global Tigecycline Historical Revenue by Application (2016-2021) 5.2.2 Global Tigecycline Forecasted Revenue by Application (2022-2027) 5.2.3 Global Tigecycline Revenue Market Share by Application (2016-2027) 5.3 Global Tigecycline Price by Application 5.3.1 Global Tigecycline Price by Application (2016-2021) 5.3.2 Global Tigecycline Price Forecast by Application (2022-2027) 6 North America 6.1 North America Tigecycline Market Size by Type 6.1.1 North America Tigecycline Sales by Type (2016-2027) 6.1.2 North America Tigecycline Revenue by Type (2016-2027) 6.2 North America Tigecycline Market Size by Application 6.2.1 North America Tigecycline Sales by Application (2016-2027) 6.2.2 North America Tigecycline Revenue by Application (2016-2027) 6.3 North America Tigecycline Market Size by Country 6.3.1 North America Tigecycline Sales by Country (2016-2027) 6.3.2 North America Tigecycline Revenue by Country (2016-2027) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Tigecycline Market Size by Type 7.1.1 Europe Tigecycline Sales by Type (2017-2027) 7.1.2 Europe Tigecycline Revenue by Type (2017-2027) 7.2 Europe Tigecycline Market Size by Application 7.2.1 Europe Tigecycline Sales by Application (2017-2027) 7.2.2 Europe Tigecycline Revenue by Application (2017-2027) 7.3 Europe Tigecycline Market Size by Country 7.3.1 Europe Tigecycline Sales by Country (2017-2027) 7.3.2 Europe Tigecycline Revenue by Country (2017-2027) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Tigecycline Market Size by Type 8.1.1 Asia Pacific Tigecycline Sales by Type (2018-2027) 8.1.2 Asia Pacific Tigecycline Revenue by Type (2018-2027) 8.2 Asia Pacific Tigecycline Market Size by Application 8.2.1 Asia Pacific Tigecycline Sales by Application (2018-2027) 8.2.2 Asia Pacific Tigecycline Revenue by Application (2018-2027) 8.3 Asia Pacific Tigecycline Market Size by Region 8.3.1 Asia Pacific Tigecycline Sales by Region (2018-2027) 8.3.2 Asia Pacific Tigecycline Revenue by Region (2018-2027) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Tigecycline Market Size by Type 9.1.1 Latin America Tigecycline Sales by Type (2019-2027) 9.1.2 Latin America Tigecycline Revenue by Type (2019-2027) 9.2 Latin America Tigecycline Market Size by Application 9.2.1 Latin America Tigecycline Sales by Application (2019-2027) 9.2.2 Latin America Tigecycline Revenue by Application (2019-2027) 9.3 Latin America Tigecycline Market Size by Country 9.3.1 Latin America Tigecycline Sales by Country (2019-2027) 9.3.2 Latin America Tigecycline Revenue by Country (2019-2027) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 6 Middle East and Africa 6.1 Middle East and Africa Tigecycline Market Size by Type 6.1.1 Middle East and Africa Tigecycline Sales by Type (2016-2027) 6.1.2 Middle East and Africa Tigecycline Revenue by Type (2016-2027) 6.2 Middle East and Africa Tigecycline Market Size by Application 6.2.1 Middle East and Africa Tigecycline Sales by Application (2016-2027) 6.2.2 Middle East and Africa Tigecycline Revenue by Application (2016-2027) 6.3 Middle East and Africa Tigecycline Market Size by Country 6.3.1 Middle East and Africa Tigecycline Sales by Country (2016-2027) 6.3.2 Middle East and Africa Tigecycline Revenue by Country (2016-2027) 6.3.3 Turkey 6.3.4 Saudi Arabia 6.3.5 U.A.E 11 Company Profiles 11.1 Pfizer 11.1.1 Pfizer Corporation Information 11.1.2 Pfizer Overview 11.1.3 Pfizer Tigecycline Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Pfizer Tigecycline Product Description 11.1.5 Pfizer Related Developments 11.2 Hisun Pharma 11.2.1 Hisun Pharma Corporation Information 11.2.2 Hisun Pharma Overview 11.2.3 Hisun Pharma Tigecycline Sales, Price, Revenue and Gross Margin (2016-2021) 11.2.4 Hisun Pharma Tigecycline Product Description 11.2.5 Hisun Pharma Related Developments 11.3 Hansoh Pharma 11.3.1 Hansoh Pharma Corporation Information 11.3.2 Hansoh Pharma Overview 11.3.3 Hansoh Pharma Tigecycline Sales, Price, Revenue and Gross Margin (2016-2021) 11.3.4 Hansoh Pharma Tigecycline Product Description 11.3.5 Hansoh Pharma Related Developments 11.4 Jiagsu Aosaikang Pharmaceutical 11.4.1 Jiagsu Aosaikang Pharmaceutical Corporation Information 11.4.2 Jiagsu Aosaikang Pharmaceutical Overview 11.4.3 Jiagsu Aosaikang Pharmaceutical Tigecycline Sales, Price, Revenue and Gross Margin (2016-2021) 11.4.4 Jiagsu Aosaikang Pharmaceutical Tigecycline Product Description 11.4.5 Jiagsu Aosaikang Pharmaceutical Related Developments 11.5 HICIN Pharma 11.5.1 HICIN Pharma Corporation Information 11.5.2 HICIN Pharma Overview 11.5.3 HICIN Pharma Tigecycline Sales, Price, Revenue and Gross Margin (2016-2021) 11.5.4 HICIN Pharma Tigecycline Product Description 11.5.5 HICIN Pharma Related Developments 11.6 Abbott Laboratories 11.6.1 Abbott Laboratories Corporation Information 11.6.2 Abbott Laboratories Overview 11.6.3 Abbott Laboratories Tigecycline Sales, Price, Revenue and Gross Margin (2016-2021) 11.6.4 Abbott Laboratories Tigecycline Product Description 11.6.5 Abbott Laboratories Related Developments 11.7 Amgen 11.7.1 Amgen Corporation Information 11.7.2 Amgen Overview 11.7.3 Amgen Tigecycline Sales, Price, Revenue and Gross Margin (2016-2021) 11.7.4 Amgen Tigecycline Product Description 11.7.5 Amgen Related Developments 11.8 Astrazeneca 11.8.1 Astrazeneca Corporation Information 11.8.2 Astrazeneca Overview 11.8.3 Astrazeneca Tigecycline Sales, Price, Revenue and Gross Margin (2016-2021) 11.8.4 Astrazeneca Tigecycline Product Description 11.8.5 Astrazeneca Related Developments 11.9 Merck 11.9.1 Merck Corporation Information 11.9.2 Merck Overview 11.9.3 Merck Tigecycline Sales, Price, Revenue and Gross Margin (2016-2021) 11.9.4 Merck Tigecycline Product Description 11.9.5 Merck Related Developments 11.10 Novartis 11.10.1 Novartis Corporation Information 11.10.2 Novartis Overview 11.10.3 Novartis Tigecycline Sales, Price, Revenue and Gross Margin (2016-2021) 11.10.4 Novartis Tigecycline Product Description 11.10.5 Novartis Related Developments 11.1 Pfizer 11.1.1 Pfizer Corporation Information 11.1.2 Pfizer Overview 11.1.3 Pfizer Tigecycline Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Pfizer Tigecycline Product Description 11.1.5 Pfizer Related Developments 11.12 Johnson & Johnson 11.12.1 Johnson & Johnson Corporation Information 11.12.2 Johnson & Johnson Overview 11.12.3 Johnson & Johnson Tigecycline Sales, Price, Revenue and Gross Margin (2016-2021) 11.12.4 Johnson & Johnson Product Description 11.12.5 Johnson & Johnson Related Developments 11.13 Sanofi 11.13.1 Sanofi Corporation Information 11.13.2 Sanofi Overview 11.13.3 Sanofi Tigecycline Sales, Price, Revenue and Gross Margin (2016-2021) 11.13.4 Sanofi Product Description 11.13.5 Sanofi Related Developments 11.14 Lifecare Innovations 11.14.1 Lifecare Innovations Corporation Information 11.14.2 Lifecare Innovations Overview 11.14.3 Lifecare Innovations Tigecycline Sales, Price, Revenue and Gross Margin (2016-2021) 11.14.4 Lifecare Innovations Product Description 11.14.5 Lifecare Innovations Related Developments 11.15 Progen Nutraceuticals 11.15.1 Progen Nutraceuticals Corporation Information 11.15.2 Progen Nutraceuticals Overview 11.15.3 Progen Nutraceuticals Tigecycline Sales, Price, Revenue and Gross Margin (2016-2021) 11.15.4 Progen Nutraceuticals Product Description 11.15.5 Progen Nutraceuticals Related Developments 12 Value Chain and Sales Channels Analysis 12.1 Tigecycline Value Chain Analysis 12.2 Tigecycline Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Tigecycline Production Mode & Process 12.4 Tigecycline Sales and Marketing 12.4.1 Tigecycline Sales Channels 12.4.2 Tigecycline Distributors 12.5 Tigecycline Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Tigecycline Industry Trends 13.2 Tigecycline Market Drivers 13.3 Tigecycline Market Challenges 13.4 Tigecycline Market Restraints 14 Key Findings in The Global Tigecycline Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Tigecycline Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Gram Positive Bacteria Table 3. Major Manufacturers of Gram Negative Bacteria Table 4. Global Tigecycline Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) Table 5. Global Tigecycline Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 6. Global Tigecycline Sales by Region (2016-2021) & (K MT) Table 7. Global Tigecycline Sales Market Share by Region (2016-2021) Table 8. Global Tigecycline Sales by Region (2016-2021) & (K MT) Table 9. Global Tigecycline Sales Market Share by Region (2022-2027) Table 10. Global Tigecycline Revenue by Region (2016-2021) & (US$ Million) Table 11. Global Tigecycline Revenue Market Share by Region (2016-2021) Table 12. Global Tigecycline Revenue by Region (2022-2027) & (US$ Million) Table 13. Global Tigecycline Revenue Market Share by Region (2022-2027) Table 14. Global Tigecycline Sales by Manufacturers (2016-2021) & (K MT) Table 15. Global Tigecycline Sales Share by Manufacturers (2016-2021) Table 16. Global Tigecycline Revenue by Manufacturers (2016-2021) & (US$ Million) Table 17. Global Tigecycline Revenue Share by Manufacturers (2016-2021) Table 18. Tigecycline Price by Manufacturers 2016-2021 (USD/MT) Table 19. Global Tigecycline Manufacturers Market Concentration Ratio (CR5 and HHI) Table 20. Global Tigecycline by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tigecycline as of 2020) Table 21. Tigecycline Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Tigecycline Product Offered Table 23. Date of Manufacturers Enter into Tigecycline Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Tigecycline Sales by Type (2016-2021) & (K MT) Table 26. Global Tigecycline Sales by Type (2022-2027) & (K MT) Table 27. Global Tigecycline Sales Share by Type (2016-2021) Table 28. Global Tigecycline Sales Share by Type (2022-2027) Table 29. Global Tigecycline Revenue by Type (2016-2021) & (US$ Million) Table 30. Global Tigecycline Revenue by Type (2022-2027) & (US$ Million) Table 31. Global Tigecycline Revenue Share by Type (2016-2021) Table 32. Global Tigecycline Revenue Share by Type (2022-2027) Table 33. Tigecycline Price by Type (2016-2021) & (USD/MT) Table 34. Global Tigecycline Price Forecast by Type (2022-2027) & (USD/MT) Table 35. Global Tigecycline Sales by Application (2016-2021) & (K MT) Table 36. Global Tigecycline Sales by Application (2022-2027) & (K MT) Table 37. Global Tigecycline Sales Share by Application (2016-2021) Table 38. Global Tigecycline Sales Share by Application (2022-2027) Table 39. Global Tigecycline Revenue by Application (2016-2021) & (US$ Million) Table 40. Global Tigecycline Revenue by Application (2022-2027) & (US$ Million) Table 41. Global Tigecycline Revenue Share by Application (2016-2021) Table 42. Global Tigecycline Revenue Share by Application (2022-2027) Table 43. Tigecycline Price by Application (2016-2021) & (USD/MT) Table 44. Global Tigecycline Price Forecast by Application (2022-2027) & (USD/MT) Table 45. North America Tigecycline Sales by Type (2016-2021) & (K MT) Table 46. North America Tigecycline Sales by Type (2022-2027) & (K MT) Table 47. North America Tigecycline Revenue by Type (2016-2021) & (US$ Million) Table 48. North America Tigecycline Revenue by Type (2022-2027) & (US$ Million) Table 49. North America Tigecycline Sales by Application (2016-2021) & (K MT) Table 50. North America Tigecycline Sales by Application (2022-2027) & (K MT) Table 51. North America Tigecycline Revenue by Application (2016-2021) & (US$ Million) Table 52. North America Tigecycline Revenue by Application (2022-2027) & (US$ Million) Table 53. North America Tigecycline Sales by Country (2016-2021) & (K MT) Table 54. North America Tigecycline Sales by Country (2022-2027) & (K MT) Table 55. North America Tigecycline Revenue by Country (2016-2021) & (US$ Million) Table 56. North America Tigecycline Revenue by Country (2022-2027) & (US$ Million) Table 57. Europe Tigecycline Sales by Type (2016-2021) & (K MT) Table 58. Europe Tigecycline Sales by Type (2022-2027) & (K MT) Table 59. Europe Tigecycline Revenue by Type (2016-2021) & (US$ Million) Table 60. Europe Tigecycline Revenue by Type (2022-2027) & (US$ Million) Table 61. Europe Tigecycline Sales by Application (2016-2021) & (K MT) Table 62. Europe Tigecycline Sales by Application (2022-2027) & (K MT) Table 63. Europe Tigecycline Revenue by Application (2016-2021) & (US$ Million) Table 64. Europe Tigecycline Revenue by Application (2022-2027) & (US$ Million) Table 65. Europe Tigecycline Sales by Country (2016-2021) & (K MT) Table 66. Europe Tigecycline Sales by Country (2022-2027) & (K MT) Table 67. Europe Tigecycline Revenue by Country (2016-2021) & (US$ Million) Table 68. Europe Tigecycline Revenue by Country (2022-2027) & (US$ Million) Table 69. Asia Pacific Tigecycline Sales by Type (2016-2021) & (K MT) Table 70. Asia Pacific Tigecycline Sales by Type (2022-2027) & (K MT) Table 71. Asia Pacific Tigecycline Revenue by Type (2016-2021) & (US$ Million) Table 72. Asia Pacific Tigecycline Revenue by Type (2022-2027) & (US$ Million) Table 73. Asia Pacific Tigecycline Sales by Application (2016-2021) & (K MT) Table 74. Asia Pacific Tigecycline Sales by Application (2022-2027) & (K MT) Table 75. Asia Pacific Tigecycline Revenue by Application (2016-2021) & (US$ Million) Table 76. Asia Pacific Tigecycline Revenue by Application (2022-2027) & (US$ Million) Table 77. Asia Pacific Tigecycline Sales by Region (2016-2021) & (K MT) Table 78. Asia Pacific Tigecycline Sales by Region (2022-2027) & (K MT) Table 79. Asia Pacific Tigecycline Revenue by Region (2016-2021) & (US$ Million) Table 80. Asia Pacific Tigecycline Revenue by Region (2022-2027) & (US$ Million) Table 81. Latin America Tigecycline Sales by Type (2016-2021) & (K MT) Table 82. Latin America Tigecycline Sales by Type (2022-2027) & (K MT) Table 83. Latin America Tigecycline Revenue by Type (2016-2021) & (US$ Million) Table 84. Latin America Tigecycline Revenue by Type (2022-2027) & (US$ Million) Table 85. Latin America Tigecycline Sales by Application (2016-2021) & (K MT) Table 86. Latin America Tigecycline Sales by Application (2022-2027) & (K MT) Table 87. Latin America Tigecycline Revenue by Application (2016-2021) & (US$ Million) Table 88. Latin America Tigecycline Revenue by Application (2022-2027) & (US$ Million) Table 89. Latin America Tigecycline Sales by Country (2016-2021) & (K MT) Table 90. Latin America Tigecycline Sales by Country (2022-2027) & (K MT) Table 91. Latin America Tigecycline Revenue by Country (2016-2021) & (US$ Million) Table 92. Latin America Tigecycline Revenue by Country (2022-2027) & (US$ Million) Table 93. Middle East and Africa Tigecycline Sales by Type (2016-2021) & (K MT) Table 94. Middle East and Africa Tigecycline Sales by Type (2022-2027) & (K MT) Table 95. Middle East and Africa Tigecycline Revenue by Type (2016-2021) & (US$ Million) Table 96. Middle East and Africa Tigecycline Revenue by Type (2022-2027) & (US$ Million) Table 97. Middle East and Africa Tigecycline Sales by Application (2016-2021) & (K MT) Table 98. Middle East and Africa Tigecycline Sales by Application (2022-2027) & (K MT) Table 99. Middle East and Africa Tigecycline Revenue by Application (2016-2021) & (US$ Million) Table 100. Middle East and Africa Tigecycline Revenue by Application (2022-2027) & (US$ Million) Table 101. Middle East and Africa Tigecycline Sales by Country (2016-2021) & (K MT) Table 102. Middle East and Africa Tigecycline Sales by Country (2022-2027) & (K MT) Table 103. Middle East and Africa Tigecycline Revenue by Country (2016-2021) & (US$ Million) Table 104. Middle East and Africa Tigecycline Revenue by Country (2022-2027) & (US$ Million) Table 105. Pfizer Corporation Information Table 106. Pfizer Description and Major Businesses Table 107. Pfizer Tigecycline Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 108. Pfizer Tigecycline Product Table 109. Pfizer Recent Developments Table 110. Hisun Pharma Corporation Information Table 111. Hisun Pharma Description and Major Businesses Table 112. Hisun Pharma Tigecycline Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 113. Hisun Pharma Tigecycline Product Table 114. Hisun Pharma Recent Developments Table 115. Hansoh Pharma Corporation Information Table 116. Hansoh Pharma Description and Major Businesses Table 117. Hansoh Pharma Tigecycline Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 118. Hansoh Pharma Tigecycline Product Table 119. Hansoh Pharma Recent Developments Table 120. Jiagsu Aosaikang Pharmaceutical Corporation Information Table 121. Jiagsu Aosaikang Pharmaceutical Description and Major Businesses Table 122. Jiagsu Aosaikang Pharmaceutical Tigecycline Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 123. Jiagsu Aosaikang Pharmaceutical Tigecycline Product Table 124. Jiagsu Aosaikang Pharmaceutical Recent Developments Table 125. HICIN Pharma Corporation Information Table 126. HICIN Pharma Description and Major Businesses Table 127. HICIN Pharma Tigecycline Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 128. HICIN Pharma Tigecycline Product Table 129. HICIN Pharma Recent Developments Table 130. Abbott Laboratories Corporation Information Table 131. Abbott Laboratories Description and Major Businesses Table 132. Abbott Laboratories Tigecycline Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 133. Abbott Laboratories Tigecycline Product Table 134. Abbott Laboratories Recent Developments Table 135. Amgen Corporation Information Table 136. Amgen Description and Major Businesses Table 137. Amgen Tigecycline Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 138. Amgen Tigecycline Product Table 139. Amgen Recent Developments Table 140. Astrazeneca Corporation Information Table 141. Astrazeneca Description and Major Businesses Table 142. Astrazeneca Tigecycline Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 143. Astrazeneca Tigecycline Product Table 144. Astrazeneca Recent Developments Table 145. Merck Corporation Information Table 146. Merck Description and Major Businesses Table 147. Merck Tigecycline Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 148. Merck Tigecycline Product Table 149. Merck Recent Developments Table 150. Novartis Corporation Information Table 151. Novartis Description and Major Businesses Table 152. Novartis Tigecycline Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 153. Novartis Tigecycline Product Table 154. Novartis Recent Developments Table 155. Roche Holdings Corporation Information Table 156. Roche Holdings Description and Major Businesses Table 157. Roche Holdings Tigecycline Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 158. Roche Holdings Tigecycline Product Table 159. Roche Holdings Recent Developments Table 160. Johnson & Johnson Corporation Information Table 161. Johnson & Johnson Description and Major Businesses Table 162. Johnson & Johnson Tigecycline Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 163. Johnson & Johnson Tigecycline Product Table 164. Johnson & Johnson Recent Developments Table 165. Sanofi Corporation Information Table 166. Sanofi Description and Major Businesses Table 167. Sanofi Tigecycline Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 168. Sanofi Tigecycline Product Table 169. Sanofi Recent Developments Table 170. Lifecare Innovations Corporation Information Table 171. Lifecare Innovations Description and Major Businesses Table 172. Lifecare Innovations Tigecycline Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 173. Lifecare Innovations Tigecycline Product Table 174. Lifecare Innovations Recent Developments Table 175. Progen Nutraceuticals Corporation Information Table 176. Progen Nutraceuticals Description and Major Businesses Table 177. Progen Nutraceuticals Tigecycline Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 178. Progen Nutraceuticals Tigecycline Product Table 179. Progen Nutraceuticals Recent Developments Table 180. Key Raw Materials Lists Table 181. Raw Materials Key Suppliers Lists Table 182. Tigecycline Distributors List Table 183. Tigecycline Customers List Table 184. Tigecycline Market Trends Table 185. Tigecycline Market Drivers Table 186. Tigecycline Market Challenges Table 187. Tigecycline Market Restraints Table 188. Research Programs/Design for This Report Table 189. Key Data Information from Secondary Sources Table 190. Key Data Information from Primary Sources List of Figures Figure 1. Tigecycline Product Picture Figure 2. Global Tigecycline Market Share by Type in 2020 & 2027 Figure 3. Gram Positive Bacteria Product Picture Figure 4. Gram Negative Bacteria Product Picture Figure 5. Global Tigecycline Sales Market Share by Application in 2020 & 2027 Figure 6. Skin & Soft Tissue Infections Figure 7. Complicated Intra-abdominal Infections Figure 8. Community-acquired Bacterial Pneumonia Figure 9. Tigecycline Report Years Considered Figure 10. Global Tigecycline Sales 2016-2027 (K MT) Figure 11. Global Tigecycline Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Tigecycline Revenue 2016-2027 (US$ Million) Figure 13. Global Tigecycline Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 14. Global Tigecycline Sales Market Share by Region (2016-2021) Figure 15. Global Tigecycline Sales Market Share by Region (2022-2027) Figure 16. North America Tigecycline Sales YoY (2016-2027) & (K MT) Figure 17. North America Tigecycline Revenue YoY (2016-2027) & (US$ Million) Figure 18. Europe Tigecycline Sales YoY (2016-2027) & (K MT) Figure 19. Europe Tigecycline Revenue YoY (2016-2027) & (US$ Million) Figure 20. Asia-Pacific Tigecycline Sales YoY (2016-2027) & (K MT) Figure 21. Asia-Pacific Tigecycline Revenue YoY (2016-2027) & (US$ Million) Figure 22. Latin America Tigecycline Sales YoY (2016-2027) & (K MT) Figure 23. Latin America Tigecycline Revenue YoY (2016-2027) & (US$ Million) Figure 24. Middle East & Africa Tigecycline Sales YoY (2016-2027) & (K MT) Figure 25. Middle East & Africa Tigecycline Revenue YoY (2016-2027) & (US$ Million) Figure 26. The Top 10 and Top 5 Players Market Share by Tigecycline Sales in 2020 Figure 27. The Top 10 and Top 5 Players Market Share by Tigecycline Revenue in 2020 Figure 28. Tigecycline Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 29. Global Tigecycline Sales Market Share by Type (2016-2027) Figure 30. Global Tigecycline Revenue Market Share by Type (2016-2027) Figure 31. Global Tigecycline Sales Market Share by Application (2016-2027) Figure 32. Global Tigecycline Revenue Market Share by Application (2016-2027) Figure 33. North America Tigecycline Sales Market Share by Type (2016-2027) Figure 34. North America Tigecycline Revenue Market Share by Type (2016-2027) Figure 35. North America Tigecycline Sales Market Share by Application (2016-2027) Figure 36. North America Tigecycline Revenue Market Share by Application (2016-2027) Figure 37. North America Tigecycline Sales Share by Country (2016-2027) Figure 38. North America Tigecycline Revenue Share by Country (2016-2027) Figure 39. U.S. Tigecycline Revenue (2016-2027) & (US$ Million) Figure 40. Canada Tigecycline Revenue (2016-2027) & (US$ Million) Figure 41. Europe Tigecycline Sales Market Share by Type (2016-2027) Figure 42. Europe Tigecycline Revenue Market Share by Type (2016-2027) Figure 43. Europe Tigecycline Sales Market Share by Application (2016-2027) Figure 44. Europe Tigecycline Revenue Market Share by Application (2016-2027) Figure 45. Europe Tigecycline Sales Share by Country (2016-2027) Figure 46. Europe Tigecycline Revenue Share by Country (2016-2027) Figure 47. Germany Tigecycline Revenue (2016-2027) & (US$ Million) Figure 48. France Tigecycline Revenue (2016-2027) & (US$ Million) Figure 49. U.K. Tigecycline Revenue (2016-2027) & (US$ Million) Figure 50. Italy Tigecycline Revenue (2016-2027) & (US$ Million) Figure 51. Russia Tigecycline Revenue (2016-2027) & (US$ Million) Figure 52. Asia Pacific Tigecycline Sales Market Share by Type (2016-2027) Figure 53. Asia Pacific Tigecycline Revenue Market Share by Type (2016-2027) Figure 54. Asia Pacific Tigecycline Sales Market Share by Application (2016-2027) Figure 55. Asia Pacific Tigecycline Revenue Market Share by Application (2016-2027) Figure 56. Asia Pacific Tigecycline Sales Share by Region (2016-2027) Figure 57. Asia Pacific Tigecycline Revenue Share by Region (2016-2027) Figure 58. China Tigecycline Revenue (2016-2027) & (US$ Million) Figure 59. Japan Tigecycline Revenue (2016-2027) & (US$ Million) Figure 60. South Korea Tigecycline Revenue (2016-2027) & (US$ Million) Figure 61. India Tigecycline Revenue (2016-2027) & (US$ Million) Figure 62. Australia Tigecycline Revenue (2016-2027) & (US$ Million) Figure 63. Taiwan Tigecycline Revenue (2016-2027) & (US$ Million) Figure 64. Indonesia Tigecycline Revenue (2016-2027) & (US$ Million) Figure 65. Thailand Tigecycline Revenue (2016-2027) & (US$ Million) Figure 66. Malaysia Tigecycline Revenue (2016-2027) & (US$ Million) Figure 67. Philippines Tigecycline Revenue (2016-2027) & (US$ Million) Figure 68. Latin America Tigecycline Sales Market Share by Type (2016-2027) Figure 69. Latin America Tigecycline Revenue Market Share by Type (2016-2027) Figure 70. Latin America Tigecycline Sales Market Share by Application (2016-2027) Figure 71. Latin America Tigecycline Revenue Market Share by Application (2016-2027) Figure 72. Latin America Tigecycline Sales Share by Country (2016-2027) Figure 73. Latin America Tigecycline Revenue Share by Country (2016-2027) Figure 74. Mexico Tigecycline Revenue (2016-2027) & (US$ Million) Figure 75. Brazil Tigecycline Revenue (2016-2027) & (US$ Million) Figure 76. Argentina Tigecycline Revenue (2016-2027) & (US$ Million) Figure 77. Middle East and Africa Tigecycline Sales Market Share by Type (2016-2027) Figure 78. Middle East and Africa Tigecycline Revenue Market Share by Type (2016-2027) Figure 79. Middle East and Africa Tigecycline Sales Market Share by Application (2016-2027) Figure 80. Middle East and Africa Tigecycline Revenue Market Share by Application (2016-2027) Figure 81. Middle East and Africa Tigecycline Sales Share by Country (2016-2027) Figure 82. Middle East and Africa Tigecycline Revenue Share by Country (2016-2027) Figure 83. Turkey Tigecycline Revenue (2016-2027) & (US$ Million) Figure 84. Saudi Arabia Tigecycline Revenue (2016-2027) & (US$ Million) Figure 85. U.A.E Tigecycline Revenue (2016-2027) & (US$ Million) Figure 86. Tigecycline Value Chain Figure 87. Tigecycline Production Process Figure 88. Channels of Distribution Figure 89. Distributors Profiles Figure 90. Bottom-up and Top-down Approaches for This Report Figure 91. Data Triangulation Figure 92. Key Executives Interviewed

Pfizer Hisun Pharma Hansoh Pharma Jiagsu Aosaikang Pharmaceutical HICIN Pharma Abbott Laboratories Amgen Astrazeneca Merck Novartis Roche Holdings Johnson & Johnson Sanofi Lifecare Innovations Progen Nutraceuticals